Dr. Pavel Goykhman, MD

Dr. Goykhman practices at Center For Advanced Cardiac And Vascular Interventions in West Hollywood, California.

Dr. Goykhman's NPI, 1174788665, was assigned on July 23, 2008. Dr. Goykhman graduated from Tel Aviv University Sackler in 2006. Dr. Goykhman holds California license A105559.

Dr. Goykhman's primary practice is Center for Advanced Cardiac and Vascular Interventions, at 948 N Fairfax Ave, West Hollywood, CA 90046-7204. The practice phone is (323) 654-2020.

Dr. Goykhman's primary practice is Center For Advanced Cardiac And Vascular Interventions in West Hollywood, California. Dr. Goykhman is also affiliated with Cedars-Sinai Medical Center. The medical group on file is Cedars-Sinai Medical Group. Dmand AI also links Dr. Goykhman to 1 more hospital, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Goykhman practices, 4 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Goykhman's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Goykhman is board certified in advanced heart failure and transplant cardiology by the American Board of Internal Medicine. Dmand AI has Dr. Goykhman's licenses on file in 2 states: California and New York.

CMS data shows 2,932 Medicare services from Dr. Goykhman across 18 procedure codes in 2024, for 676 Medicare patients. Medicare paid $263,939 for them.

CMS counts 676 Medicare patients who saw Dr. Goykhman in 2024. The largest group is 75 to 84, with 257 patients. 75% of them have arthritis, and 75% have high blood pressure. 73% are also on Medicaid. Their average risk score is 1.99, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Goykhman's median patient age at 76, with 55% women.

In 2024, Dr. Goykhman wrote 5,138 Medicare Part D claims for 354 patients. 82% of them were for generic drugs. CMS names the drug for 4,908 of them, across 54 drugs with 11 or more claims each, at $502,769 in total drug cost. In 2023, CMS named 3,460 claims across 47 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Goykhman for performance year 2024, reported individually. Dr. Goykhman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 8 papers to Dr. Goykhman, published from 2010 to 2012. 2011 was the busiest year, with 2. Dr. Goykhman's most frequent co-authors are Megha Agarwal, MD, Ryan Patrick Morrissey, MD and Daniel S. Berman, MD.

CMS Open Payments shows 101 general payments to Dr. Goykhman from 24 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 87% of the total. Boston Scientific Corporation paid the most, $738.

Dr. Goykhman graduated from Tel Aviv University Sackler in 2006.

Dr. Goykhman is in network with 10 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.